Geir Ove Aaker • 1966 • Dønna • 15 roles • 8 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
G G.O.AAKER AS	Managing Director/CEO	-	-3,195,627	100 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
G GEIR OVE INVEST AS	Contact Person	-	247,304,252	100 % directly
G G.O.AAKER AS	Chairman	-	-3,195,627	100 % indirectly
Å ÅKERGUTTEN AS	Chairman	4,304,624	28,693,248	49 % indirectly
B BRUGATA 50 OG 56 HOLDING AS	Board Member	-	16,770,349	47.73 % indirectly
B BRUGATA 50 OG 56 AS	Board Member	4,041,641	-3,551,293	47.73 % indirectly
Å ÅKERØYA AS	Chairman	476,082	38,272,139	31.44 % indirectly
S SALMO PHARMA AS	Alternate Member	41,024	25,855,000	6.29 % indirectly
A A.I.AAKER AS	Board Member	-	72,302	-
G GA MARITIM DA	Contact Person	-	-	-
B BERFJORD PROSJEKT AS	Board Member	358,300	-3,064,662	-
E EGSA INVEST AS	Contact Person	-	13,223,582	-

Last update: Sep 16, 2023

Related industries4

Real estate activities
Professional, scientific and technical activities
Manufacturing
Agriculture, forestry and fishing

Direct relationships5

JB
Jonny Berfjord1963
BRUGATA 50 OG 56 HOLDING AS, SALMO PHARMA AS, A.I.AAKER AS, ÅKERØYA AS, BERFJORD PROSJEKT AS, BRUGATA 50 OG 56 AS, G.O.AAKER AS
AI
Arnt Inge Aaker1972
A.I.AAKER AS, ÅKERØYA AS, BERFJORD PROSJEKT AS, G.O.AAKER AS
EG
Eskil Georg Sørvik Aaker1999
GA MARITIM DA, ÅKERGUTTEN AS, EGSA INVEST AS
AM
Alf Martin Ulven1960
BRUGATA 50 OG 56 HOLDING AS, BRUGATA 50 OG 56 AS
RN
Roar Nilsen1962
BRUGATA 50 OG 56 HOLDING AS, BRUGATA 50 OG 56 AS

Shares owned by Geir Ove Aaker

Name	Share class	Total operating income	Total equity	Share
G GEIR OVE INVEST AS	Ordinære aksjer	0	247,304,252	100 % directly
G G.O.AAKER AS		0	-3,195,627	100 % indirectly
Å ÅKERGUTTEN AS		4,304,624	28,693,248	49 % indirectly
B BRUGATA 50 OG 56 HOLDING AS		0	16,770,349	47.73 % indirectly
B BRUGATA 50 OG 56 AS		4,041,641	-3,551,293	47.73 % indirectly
Å ÅKERØYA AS		476,082	38,272,139	31.44 % indirectly
B BRISKEBYEN UTVIKLING AS		0	264,235	23.86 % indirectly
S SALMO PHARMA AS		41,024	25,855,000	6.29 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024